prazosin has been researched along with Takotsubo Cardiomyopathy in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Takotsubo Cardiomyopathy: A transient left ventricular apical dysfunction or ballooning accompanied by electrocardiographic (ECG) T wave inversions. This abnormality is associated with high levels of CATECHOLAMINES, either administered or endogenously secreted from a tumor or during extreme stress.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakamoto, K | 1 |
| Kojima, S | 1 |
| Hokimoto, S | 1 |
| Ogawa, H | 1 |
1 other study available for prazosin and Takotsubo Cardiomyopathy
| Article | Year |
|---|---|
Pheochromocytoma multisystem crisis with transient stress cardiomyopathy due to ruptured pheochromocytoma.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenalectomy; Antihypertensive Agents; Breast Neop | 2015 |